Success Metrics

Clinical Success Rate

50.0%

Based on 2 completed trials

Completion Rate

50%(2/4)

Active Trials

0(0%)

Results Posted

150%(3 trials)

Terminated

2(40%)

Phase Distribution

Ph early_phase_1

20%

Ph not_applicable

20%

Ph phase_1

20%

Ph phase_2

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Early Phase 1First-in-human

1(25.0%)

Phase 1Safety & dosage

1(25.0%)

Phase 2Efficacy & side effects

1(25.0%)

N/ANon-phased studies

1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

40.0%

2 of 5 finished

Non-Completion Rate

60.0%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(3)

Detailed Status

Terminated2

Completed2

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 2

Trials by Phase

Early Phase 11 (25.0%)

Phase 11 (25.0%)

Phase 21 (25.0%)

N/A1 (25.0%)

Trials by Status

withdrawn120%

terminated240%

completed240%

Recent Activity

0 active trials

Showing 5 of 5

completedearly_phase_1

Endometrial Transcript Profile with Progesterone After Post-ovulatory Mifepristone

NCT06616077

withdrawn

Mifepristone Versus Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks

NCT00986921

Clinical Trials (5)

Showing 5 of 5 trials

NCT06616077Early Phase 1

Endometrial Transcript Profile with Progesterone After Post-ovulatory Mifepristone

Completed

NCT05062174

Breast Cancer BRCA1 Carriers: a Pilot Study

Withdrawn

NCT03714880Phase 2

Cervical Preparation With Mifepristone Prior to Osmotic Dilators

Terminated

NCT03774745Phase 1

Blocking Mifepristone Action With Progesterone

Terminated

NCT00986921Not Applicable

Mifepristone Versus Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5